Enduracidin
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-01782 |
| CAS | 11115-82-5 |
| Molecular Weight | 2550.21 (Enramycin A); 2564.24 (Enramycin B) |
| Molecular Formula | C107H138Cl2N26O31 (Enramycin A); C108H140Cl2N26O31 (Enramycin B) |
| Purity | >95% |
Online Inquiry
Description
It is produced by the strain of Streptomyces fungicidicus. Enramycin is a polypeptide antibiotic, and it has anti-gram-positive bacteria and mycobacterium activity. Enramycin is composed of two different compounds: Enramycin A and enramycin B.
Specification
| Synonyms | Enramycin; Enramycin Premix; Enramicina; Enramycinum; Enradin |
| Storage | -20 °C |
Properties
| Appearance | Light Yellow Powder |
| Antibiotic Activity Spectrum | Gram-positive bacteria; Mycobacteria |
| Melting Point | 234-238 °C (dec.) |
| Solubility | Soluble in Hydrochloric acid |
Reference Reading
1. Semi-rational mutagenesis of an industrial Streptomyces fungicidicus strain for improved enduracidin productivity
Huitu Zhang, Ying Guan, Yue Wang, Tao Yu, Xiaonong Wu, Zilong He, Guoguo Wu, Fuping Lu, Qianhui Zhu, Rong Yue, Jing Zhang, JinTian Xu, Songnian Hu, Shuting Song Appl Microbiol Biotechnol . 2020 Apr;104(8):3459-3471. doi: 10.1007/s00253-020-10488-0.
The biosynthesis of the valuable antibiotic enduracidin by Streptomyces fungicidicus TXX3120 is a complex multistep process. To identify the rate-limiting step of the entire biosynthetic process, we carried out a deep RNA sequencing towards the mycelia of TXX3120 at different fermentation stages. Comparative RNA-seq analysis indicated that the expression level of the endC gene during the enduracidin production phase was evidently lower than that of the other relevant genes to enduracidin biosynthesis. This result was further confirmed by quantitative RT-PCR, and the giant non-ribosomal peptide synthase (NRPS) encoded by endC was predicated to be the rate-limiting enzyme in enduracidin biosynthesis. To increase the expression of endC during the enduracidin production phase, a reporter-based selection system was developed by genetically replacing the initial part of the endC gene with a thiostrepton resistance gene (tsr), which will then act as a selectable marker to report the expression level of the rate-limiting gene endC, thereby facilitating the selection of enduracidin-overproducing mutants following random mutagenesis. After one round of mutagenesis, thiostrepton resistance selection, and restoration of the endC gene, three mutant strains with improved endC expression levels were obtained. Their highest enduracidin titers reached 9780.54, 9272.46, and 8849.06 U/mL, respectively representing 2.31-, 2.19-, and 2.09-fold of the initial industrial strain TXX3120. Our research provides a useful strategy for the rational breeding of industrial strains that synthesize complex natural products.
2. Discovery, gene modification, and optimization of fermentation of an enduracidin-producing strain
Xian-Wen Yang, Tian-Hua Zhong, Zhu-Hua Chan, Wei Xu, Yong-Hong Zhang, Xian-Ming Zeng, Zhu-Hua Luo J Asian Nat Prod Res . 2018 Jul;20(7):633-648. doi: 10.1080/10286020.2018.1451517.
Enduracidin significantly inhibits Gram-positive bacteria and had been widely used in many fields. However, as the poor technology for production of enduracidin and its scarcity, identification of novel strategies for production of enduracidin is important. Our group developed two methods to improve the yield of the production of enduracidin. The yield of enduracidin was increased by three- to fivefold. The highest yields of enduracidin A and enduracidin B achieved were 63.7 and 82.13 mg/ml. Thus, our results might provide a new reference method for the industrial production of enduracidin.
3. The enduracidin biosynthetic gene cluster from Streptomyces fungicidicus
Xihou Yin, T Mark Zabriskie Microbiology (Reading) . 2006 Oct;152(Pt 10):2969-2983. doi: 10.1099/mic.0.29043-0.
The biosynthetic gene cluster for the 17 aa peptide antibiotic enduracidin has been cloned and sequenced from Streptomyces fungicidicus ATCC 21013. The 84 kb gene cluster contains 25 ORFs and is located within a 116 kb genetic locus that was fully sequenced. Targeted disruption of non-ribosomal peptide synthetase (NRPS) genes in the cluster abolished enduracidin production and confirmed function. The cluster includes four genes, endA-D, encoding two-, seven-, eight- and one-module NRPSs, respectively, and includes unique modules for the incorporation of citrulline and enduracididine. The NRPS organization generally follows the collinearity principle, and starts with a condensation domain (C domain) similar to those found in other lipopeptide systems for the coupling of an acyl group to the starting amino acid. The sixth module of EndB, corresponding to Thr(8), is missing an adenylation domain (A domain) and this module is presumed to be loaded in trans by the single module protein EndD. The most striking feature of the NRPS organization is the lack of epimerization domains (E domains) in light of the fact that the product has seven d-amino acid residues. Sequence analysis reveals that C domains following modules corresponding to d-amino acids belong to a unique subset of C domains able to catalyse both epimerization and condensation reactions. Other genes directing lipid modification and activation, and formation of the non-proteinogenic amino acids 4-hydroxyphenylglycine and enduracididine are readily identified, as are genes possibly involved in regulation of antibiotic biosynthesis and export. These findings provide the basis to further genetically manipulate and improve lipodepsipeptide antibiotics via combinatorial and chemical methods.
Recommended Products
| BBF-01826 | Deoxymannojirimycin | Inquiry |
| BBF-03753 | Baicalin | Inquiry |
| BBF-03755 | Actinomycin D | Inquiry |
| BBF-03754 | CASTANOSPERMINE | Inquiry |
| BBF-01693 | Doxorubicin EP Impurity A (Daunorubicin) | Inquiry |
| BBF-02614 | Nystatin | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
